|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05.08.26 - 07:54
|
India′s Inflation Cushion ′Thinner′ Than It Seems (Bloomberg)
|
|
|
The Reserve Bank of India kept its benchmark rate unchanged for a fourth straight review as it waits to see whether higher energy costs from the Iran war spill over into broader inflation. Prior to the decision, Standard Chartered Bank Head of India Economic Research Anubhuti Sahay told us the country's inflation has been benign so far, but the cushion is thinner than it appears. She speaks with Paul Allen on Bloomberg's "Insight with Haslinda Amin." (Source: Bloomberg)...
|
|
|
04.08.26 - 09:48
|
KKR-Backed Infinx Services Said to Weigh $300 Million India IPO (Bloomberg)
|
|
|
Infinx Services Pvt., a healthcare revenue cycle management company, is considering an initial public offering of as much as $300 million in India, according to people familiar with the matter, joining a growing pipeline of healthcare services firms seeking to tap the country's buoyant equity markets....
|
|
|
|
|
|
|
|
|
24.07.26 - 14:36
|
Sensex down 900 points, Nifty50 ends below 23,800: Why stock market crashed today (Times of India)
|
|
|
Indian stock markets closed lower for a fifth consecutive session on Friday. Rising oil prices and Middle East tensions fueled investor caution and market pressure. Foreign institutional investors continued their selling trend, impacting market sentiment negatively. Renewed concerns over US trade tariffs also contributed to the overall market decline. Selling in heavyweight stocks like Infosys and HDFC Bank added to the day's losses....
|
|
|
22.07.26 - 16:33
|
UBS Warns Trump′s 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners (ZeroHedge)
|
|
|
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US.
"This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them," Trump wrote on Truth Social late Tuesday.
He continued, "The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is," adding, "Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America."
Trump's announcement is the latest effort to reshore critical supply chains, and in this case, boost domestic productio...
|
|
|
|
|
|
|
|
|
|
|
|